J
Jamie Case
Researcher at Scripps Health
Publications - 73
Citations - 2864
Jamie Case is an academic researcher from Scripps Health. The author has contributed to research in topics: Progenitor cell & CD34. The author has an hindex of 22, co-authored 72 publications receiving 2703 citations. Previous affiliations of Jamie Case include Indiana University – Purdue University Indianapolis & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
In vitro effect of chlorambucil on human glioma cell lines (SF767 and U87-MG), and human microvascular endothelial cell (HMVEC) and endothelial progenitor cells (ECFCs), in the context of plasma chlorambucil concentrations in tumor-bearing dogs.
Michael J. Reese,Deborah W. Knapp,Kimberly M. Anderson,Julie A. Mund,Jamie Case,David R. Jones,Rebecca A. Packer +6 more
TL;DR: Results suggest that metronomic chlorambucil in dogs does not achieve plasma concentrations high enough to cause direct cytotoxic or growth inhibitory effects on either glioma or endothelial cells.
Journal ArticleDOI
A Pilot Study of Circulating Endothelial and Hematopoietic Progenitor Cells in Children With Sarcomas.
Kamnesh R. Pradhan,Julie A. Mund,Heather L. Claussen,Yasmin Gosiengfiao,Vlad C. Radulescu,Jennifer J. Ballard,Ziyue Liu,Terry A. Vik,Jamie Case +8 more
TL;DR: A validation of CECs as prognostic biomarker is now warranted based on the results of a multiparametric flow cytometry protocol assessed various cell types implicated in tumor angiogenesis that were found circulating in the peripheral blood of children with sarcomas.
Journal ArticleDOI
UNOS/OPTN data guided assessment of IgA nephropathy recurrence after kidney transplantation and evaluation of immunosuppressive protocols in a steroid free center
Sunil M. Kurian,Samantha R. Spierling Bagsic,Jamie Case,Bethany Barrick,Randolph Schaffer,James C. Rice,Christopher L. Marsh +6 more
TL;DR: It is believed that it is safe to continue the steroid avoidance protocols at SCOT and think that it may be beneficial, given the adverse effects and toxicities associated with steroid use.
Journal ArticleDOI
CD34+AC133+VEGFR-2+ Cells Are Primitive Hematopoietic Progenitors, Not Functional Endothelial Progenitor Cells.
Jamie Case,Laura E. Mead,Hilary White,Mohammad Reza Saadatzadeh,Mervin C. Yoder,Laura S. Haneline,David A. Ingram +6 more
TL;DR: Data demonstrate that circulating CD34 + AC133 + VEGFR-2 + cells are HPCs and the biologic mechanism for their correlation with cardiovascular disease needs to be re-examined.